10 Jul Aetna Launches Precision Medicine Efforts to Improve Health Outcomes and Decrease Costs
The payer arena is starting to embrace precision medicine to improve overall health outcomes and enhance cost-savings. For example, Aetna is now leading the way with a new precision medicine program that embraces breast and ovarian cancer testing program using the BRCA gene test. Aetna is also implementing a genetic information privacy policy, becoming the first health plan to require quality credentialing of genetic testing labs. With the number of genetic tests increasing to more than...